Covid vaccine monitoring: when will a coronavirus vaccine be ready? | World news



vaccines not yet in human trials


Phase 1

vaccines in small-scale safety trials


Phase 2

vaccines in expanded safety trials


Phase 3

vaccines in large-scale efficacy trials



vaccines approved for general use


Source: WHO. Last update 30 Sep.

Researchers around the world are rushing to develop a vaccine for Covid-19, with more than 170 vaccine candidates now being tracked by the World Health Organization (WHO).

Vaccines normally take years of testing and additional time to be produced on a large scale, but scientists hope to develop a vaccine for the coronavirus within 12 to 18 months.

Vaccines mimic the virus – or part of the virus – that they protect against, stimulating the immune system to develop antibodies. They must meet higher safety standards than other drugs because they are given to millions of healthy people.

Recent vaccine news

University of Oxford / AstraZeneca vaccine trials resumed after a brief hiatus to investigate the case of a participant who fell ill.

The WHO has said it does not expect widespread vaccinations against the coronavirus until mid-2021.

How are vaccines tested?

in the preclinical stage In tests, researchers give the vaccine to animals to see if it triggers an immune response.

In phase 1 In clinical trials, the vaccine is given to a small group of people to determine if it is safe and to learn more about the immune response it elicits.

In phase 2, the vaccine is given to hundreds of people so that scientists can learn more about its safety and correct dosage.

In phase 3, the vaccine is given to thousands of people to confirm its safety – including its rare side effects – and its effectiveness. These trials involve a control group that receives a placebo.

Vaccines in clinical trials

Current phase

Phase completed

University of Oxford / AstraZeneca

BioNTech / Fosun Pharma / Pfizer

CanSino Biologics Inc./ Beijing Biotechnology Institute

Wuhan Institute of Biologics / Sinopharm

Janssen Pharmaceutical Companies

Gamaleya Research Institute

Beijing Institute of Biologics / Sinopharm

Institute for Research on Biosafety Problems, Republic of Kazakhstan

Inovio Pharmaceuticals / Institut international des vaccins

Osaka University / AnGes / Takara Bio

Institute of Medical Biology, Chinese Academy of Medical Sciences

SpyBiotech / Serum Institute of India

Anhui Zhifei Longcom Biopharmaceutical / Institute of Microbiology, Chinese Academy of Sciences

Kentucky Bioprocessing, Inc

Cadila Healthcare Limited

Beijing Wantai Organic Pharmacy / Xiamen University

Clover Biopharmaceuticals Inc./GSK/Dynavax

VECTEUR FBRI SRC VB, Rospotrebnadzor, Koltsovo

West China Hospital, Sichuan University

ReiThera / LEUKOCARE / Univercells

Medigen Vaccine Biologics Corporation / NIAID / Dynavax

Institut Pasteur / Themis / Univ. de Pittsburg CVR / Merck Sharp & Dohme

Tuebingen University Hospital

Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China

Finlay Vaccine Institute, Cuba

University of Queensland / CSL / Seqirus

People’s Liberation Army (APL) / Walvax Biotech Academy of Military Sciences.

University of Melbourne / Murdoch Children’s Research Institute

Source: WHO. Last update 30 Sep.


Please enter your comment!
Please enter your name here